Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

4.55
+0.01000.22%
Post-market: 4.550.00000.00%16:20 EDT
Volume:101.45K
Turnover:456.25K
Market Cap:172.23M
PE:-4.92
High:4.59
Open:4.55
Low:4.37
Close:4.54
52wk High:8.98
52wk Low:3.63
Shares:37.85M
Float Shares:19.33M
Volume Ratio:0.97
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-12.13
PE(LYR):-8.43

Loading ...

Lifecore Biomedical Signs New Agreement With Global Pharmaceutical Company

THOMSON REUTERS
·
Jun 15

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

GlobeNewswire
·
Jun 15

Lifecore Biomedical Signs Manufacturing Services Agreement With Ophthalmic Customer

MT Newswires Live
·
Jun 02

Lifecore Biomedical signs manufacturing services deal with new ophthalmic customer

Reuters
·
Jun 02

Lifecore Biomedical Signs Agreement With New Biopharmaceutical Customer

THOMSON REUTERS
·
Jun 02

Lifecore Biomedical attends William Blair Growth Stock Conference

Reuters
·
May 21

Lifecore Biomedical attends CDMO Live Europe, joins tech transfer panel

Reuters
·
May 13

Lifecore reports Q1 EPS (43c), consensus (29c)

TIPRANKS
·
May 07

Lifecore Biomedical Q1 revenue falls 34%, misses analyst estimates

Reuters
·
May 06

BRIEF-Lifecore Biomedical Q1 Revenue USD 23.2 Million

Reuters
·
May 06

Lifecore Biomedical Inc - Reaffirms 2026 Revenue and Adj Ebitda Guidance

THOMSON REUTERS
·
May 06

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

GlobeNewswire
·
May 06

Lifecore Biomedical Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
May 04

Lifecore Biomedical Is Maintained at Outperform by Barrington Research

Dow Jones
·
Apr 30

Lifecore Biomedical to report first-quarter results, host webcast

Reuters
·
Apr 30

Barrington Raises Price Target on Lifecore Biomedical to $6 From $5.50, Keeps Outperform Rating

MT Newswires Live
·
Apr 29

Lifecore price target raised to $6 from $5.50 at Barrington

TIPRANKS
·
Apr 29

Lifecore Biomedical announces 2026 annual shareholder meeting

Reuters
·
Apr 25

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 23

Lifecore Biomedical to attend American Biomanufacturing Summit, discuss injectables CDMO services

Reuters
·
Apr 08